1. Home
  2. CRDO vs ROIV Comparison

CRDO vs ROIV Comparison

Compare CRDO & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Credo Technology Group Holding Ltd

CRDO

Credo Technology Group Holding Ltd

HOLD

Current Price

$216.70

Market Cap

32.2B

Sector

Technology

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$30.22

Market Cap

21.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRDO
ROIV
Founded
2008
2014
Country
Cayman Islands
United Kingdom
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.2B
21.0B
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
CRDO
ROIV
Price
$216.70
$30.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
9
Target Price
$179.62
$28.94
AVG Volume (30 Days)
5.2M
5.5M
Earning Date
06-01-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
261.11
N/A
EPS
1.62
N/A
Revenue
$436,775,000.00
$8,260,000.00
Revenue This Year
$210.92
N/A
Revenue Next Year
$57.22
$744.61
P/E Ratio
$119.57
N/A
Revenue Growth
126.34
N/A
52 Week Low
$59.21
$10.71
52 Week High
$213.80
$32.79

Technical Indicators

Market Signals
Indicator
CRDO
ROIV
Relative Strength Index (RSI) 64.41 56.00
Support Level $129.63 $26.65
Resistance Level N/A N/A
Average True Range (ATR) 17.42 1.12
MACD -0.88 0.20
Stochastic Oscillator 98.46 48.05

Price Performance

Historical Comparison
CRDO
ROIV

About CRDO Credo Technology Group Holding Ltd

Credo Technology Group Holding Ltd delivers high-speed solutions to break bandwidth barriers on every wired connection in the data infrastructure market. It provides secure, high-speed connectivity solutions that deliver improved power and cost efficiency as data rates and corresponding bandwidth requirements increase exponentially throughout the data infrastructure market. It has a geographic presence in Hong Kong, the United States, Mainland China, Taiwan, and the Rest of the World.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: